Abstract
The European Directive 98/79/EC on in vitro diagnostics (IVD) regulates marketing and post market surveillance of IVD in the European Economic Area. In cases of incidents and field safety corrective actions (FSCA) manufacturers have to inform responsible competent authority (CA) and public by field safety notices (FSN). We analyzed FSCA and FSN of IVD for infection testing (culture media, reagents, kits, control materials, as well as culture-based analyzers and their general consumables) published by the Federal Institute for Drugs and Medical Devices (BfArM) in Bonn, Germany in 2005–2012 in regard to the European Regulatory Framework of Medical Devices (MEDDEV). One hundred and sixty-nine FSCA were published and German and English FSN were found in 157 and 154 cases, respectively. FSN were clearly characterized as FSN in 110 German and 134 English cases and product names were provided in 157 and 154 cases, respectively. Lot numbers and other information for product characterization were available in 146 and 137 cases, respectively. The information regarding FSCA and product malfunction was provided in 157 and 151 and 144 and 136 cases and that regarding the product related risks with continued use of affected IVD in 116 and 116 cases, respectively. In 156 German and 152 English cases, manufacturers provided the information for risk mitigation, including retesting in 69 and 75 cases, respectively. Requests to pass FSN to persons needing awareness were found in 108 and 87 cases, and contact data were provided in 127 and 131 cases, respectively. We conclude that most FSN fulfilled the MEDDEV criteria. However, type and content of FSN should be improved to ensure a better mitigation of risks due to product failure.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
BfArM homepage (2013) http://www.bfarm.de/SiteGlobals/Forms/Suche/Filtersuche_Produktgruppe_Formular.html?nn=3494892. Accessed 14 Nov 2013
Bornhak H, Dörr V, Halbauer J, Meyer-Lüerßen D, Odenthal J, Siekmeier R, Will HG (2002) Die Anforderungen der Medizinprodukte-Sicherheitsplanverordnung für in vitro-Diagnostika im Rahmen des Medizinproduktegesetzes. MedizinProdukteRecht 4:120–133
Directive 98/79/EC of the European Parliament and of the Council on In vitro diagnostic medical devices (1998) Official Journal L 331:1–37. http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CELEX:31998L0079:en:html. Accessed 6 Jan 2014
Guidelines on a medical devices vigilance system (2013) MEDDEV 2.12-1 rev. 8/Internet: http://ec.europa.eu/health/medical-devices/files/meddev/2_12_1_ol_en.pdf. Accessed 6 Jan 2014
Halbauer J, Siekmeier R, Funk M (2009) Die Sicherheit von Hochrisiko-in vitro-Diagnostika. Internationale und nationale Maßnahmen. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 52:610–618
Hannig J, Siekmeier R (2013) Quality of customer information in product problems of point of care tests and analysers for blood gases and electrolytes published by BfArM 2005–2011. Wiener Klinische Wochenschrift 125:651
Medical devices post market surveillance (2009) National Competent Authority report exchange criteria and report form. (GHTF/SG2/N79R11:2009)/http://www.imdrf.org/docs/ghtf/final/sg2/technical-docs/ghtf-sg2-n79r11-medical-devices-post-market-surveillance-090217.pdf. Accessed 6 Jan 2014
Medizinproduktegesetz in der Fassung der Bekanntmachung vom 7 August 2002 (BGBl. I S. 3146), geändert durch Artikel 1 des Gesetzes vom 14 Juni 2007 (BGBl. I S. 1066), zuletzt geändert durch Artikel 6 des Gesetzes vom 29 Juli 2009 (BGBl. I S. 2326). http://www.gesetze-im-internet.de/bundesrecht/mpg/gesamt.pdf. Accessed 6 Jan 2014
Siekmeier R, Lütz J (2007a) Experience with post-market surveillance of in vitro diagnostic medical devices for lay use in Germany. Clin Chem Lab Med 45:396–401
Siekmeier R, Lütz J (2007b) Safety of in vitro-diagnostics for hematology and coagulation testing – analysis of the reports to the German Competent Authority (BfArM). Transfus Med Hemother 34:353–361
Siekmeier R, Wetzel D (2013a) Market surveillance of in vitro diagnostics by the BfArM until end 2010: safety of IVD for therapeutic drug monitoring? Adv Exp Med Biol 755:375–383
Siekmeier R, Wetzel D (2013b) Market surveillance of in vitro diagnostics by the BfArM until end 2010: how safe are products for tumor diagnostics? Adv Exp Med Biol 755:385–396
Siekmeier R, Halbauer J, Mientus W, Wetzel D (2008) Safety of reagents for infection testing: results of the market surveillance by the Federal Institute for Drugs and Medicinal Devices until end 2006. J Physiol Pharmacol 59(Suppl 6):629–643
Siekmeier R, Behmann I, Schröder D, Wetzel D (2009a) Neue Trends bei Meldungen zu Systemen zur Blutzuckerselbstmessung – Vergleich der Meldezeiträume vor und seit 2006. Wien Klin Wochenschr 121:A19–A20
Siekmeier R, Halbauer J, Mientus W, Wetzel D (2009b) Safety of laboratory analyzers for infection testing – results of the market surveillance by the BfArM until end 2007. Eur J Med Res 14(Suppl IV):216–226
Siekmeier R, Lisson K, Wetzel D (2010) Field safety notices related by manufacturers in cases of failure of products for infection testing: analysis of cases reported to the BfArM between 2005 and 2007. Eur J Med Res 15(Suppl II):175–183
Spitzenberger F, Edelhäuser R, Funk M, Halbauer J (2007) Vigilance experience for high-risk IVDs in Europe. Regul Affairs J Devices 15:157–164
Verordnung über die Erfassung, Bewertung und Abwehr von Risiken bei Medizinprodukten (Medizinprodukte-Sicherheitsplanverordnung – MPSV) (2002) (BGBl. I S. 2131), zuletzt geändert durch Artikel 3 des Gesetzes vom 29. Juli 2009 (BGBl. I S. 2326). http://www.gesetze-im-internet.de/mpsv/index.html. Accessed 6 Jan 2014
Conflicts of Interest
The authors report no conflicts of interest in relation to this article.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Hannig, J., Siekmeier, R. (2014). Does Customer Information Fulfill MEDDEV Criteria in Cases of Product Problems of In Vitro Diagnostics for Infection Testing?. In: Pokorski, M. (eds) Respiratory Infections. Advances in Experimental Medicine and Biology(), vol 835. Springer, Cham. https://doi.org/10.1007/5584_2014_24
Download citation
DOI: https://doi.org/10.1007/5584_2014_24
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-10014-2
Online ISBN: 978-3-319-10015-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)